The Next Pandemic?
For anyone aware that Sars-Cov-2 was developed as an animal (bat) vaccine and with knowledge of Fouchiers H5N1 GOF work (the Baric of Influenza viruses) and its restart of funding in 2019 this should scare the hell out of you
Incoming WHO chief scientist Jeremy Farrar said he would like to see the pharmaceutical industry at least conduct some clinical trials for all influenza strains such that the world would not have to start from scratch to initiate global manufacturing should the need arise.
"My concern that we're in slow motion watching something which may never happen," he added in a media briefing. "But if it were to happen, would we look back on what we're doing at the moment and say, why didn't we do more?"
Farrar is a clinical scientist who most recently served as the director of the Wellcome Trust. He was appointed as the WHO's chief scientist in December, and will formally join the agency later this year.
https://www.reuters.com/business/healthcare-pharmaceuticals/develop-vaccines-all-animal-influenza-strain-says-incoming-who-chief-scientist-2023-02-20/
The easiest way to vaccinate animals in the wild is with self spreading vaccines using a self spreading Live Attenuated Virus (LAV).
More on Fouchiers research here
The Dutch virologist, based at Erasmus Medical Center in Rotterdam, caused a firestorm of controversy about a decade ago, when he and Yoshihiro Kawaoka at the University of Wisconsin-Madison announced that they had successfully mutated H5N1, a strain of bird flu, to pass through the air between ferrets, in two separate experiments. Ferrets are considered the best flu models because their respiratory systems react to the flu much like humans.
In 2014, in response to researchers’ fears and some lab incidents, the federal government imposed a moratorium on all GOF research, freezing the work
The National Academy of Science whipped up some new guidelines, and in December of 2017, the call went out: GOF studies could apply to be funded again. A panel formed by Health and Human Services (HHS) would review applications and make the decision of which studies to fund.
As of right now, only Kawaoka and Fouchier’s studies have been approved, getting the green light last winter. They are resuming where they left off.
https://bigthink.com/health/covid-gain-of-function-research/
Fortunately Cambodia says no person to person transmission, but thats what China said early in 2020
1/
2/
3/
Catastrophic contagion Exercise (Event 202?)
Targeting young people
https://www.centerforhealthsecurity.org/our-work/exercises/2022-catastrophic-contagion/
Bill and Melinda discussing the next pandemic which will “get our attention”
Flu vaccine-These idiots will never learn
The “multivalent” vaccine, which the researchers describe in a paper published today in Science, uses the same messenger ribonucleic acid (mRNA) technology employed in the Pfizer and Moderna SARS-CoV-2 vaccines. This mRNA technology that enabled those COVID-19 vaccines was pioneered at Penn. Tests in animal models showed that the vaccine dramatically reduced signs of illness and protected from death, even when the animals were exposed to flu strains different from those used in making the vaccine
https://www.pennmedicine.org/news/news-releases/2022/november/penn-develops-mrna-flu-vaccine
February 16, 2023
mRNA-1010 demonstrated superiority on seroconversion rates for A/H3N2 and A/H1N1, superiority on geometric mean titer ratios for A/H3N2, and non-inferiority on geometric mean titer ratios for A/H1N1
Non-inferiority was not met for seroconversion rates and geometric mean titer ratios for the influenza B/Victoria- and B/Yamagata-lineage strains
mRNA-1010 showed an acceptable safety and tolerability profile
Separate parallel pivotal Phase 3 efficacy study has now accrued over 200 PCR-confirmed cases, almost all influenza A consistent with the burden of disease in older adults; an independent DSMB is expected to review the first interim analysis of efficacy by the end of 1Q
mRNA-1010 is one of five influenza vaccine candidates being evaluated by Moderna
CAMBRIDGE, MA / ACCESSWIRE / February 16, 2023 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced interim results from its pivotal Phase 3 safety and immunogenicity trial of mRNA-1010 (P301), an mRNA-based seasonal influenza (flu) vaccine candidate, in adults. The Phase 3 randomized trial was designed to evaluate the safety and immunogenicity of mRNA-1010 in adults 18 years and older in the Southern Hemisphere. mRNA-1010 encodes for hemagglutinin (HA)
Moderna shares dropping like a stone as earnings disappoint , increased Royalties and bleak future for COVID misery jabs . So they need a new Pandemic
https://www.fool.com/investing/2023/02/24/why-moderna-stock-dropped-today/
It does look like the Pandemic Dream Team is gearing up for round 2
After all, round 1 worked better than expected. Most Americans stayed on the couch content to Tweet (or whatever Social media platform they are on) their protests that algorithms muzzled. Public Opinion matters only in a Democracy, and its doubtful we have one. Besides, they know how to rig elections. I doubt we have had an honest election in the 2000’s
Hopefully I am wrong and this fizzles like Monkey Pox. Just in case, you might want to stock up on toilet paper. Baric said in March (Friday 13th) 2020 on TWIV that he was selling his stockpile at 10$ a roll. Nobody asked how he knew to stockpile toilet paper.
At around 2 minutes
https://asm.org/Podcasts/TWiV/Episodes/Coronavirus-update-with-Ralph-Baric-TWiV-591
Where might such a Biological Weapon be released?
Hmm, I wonder how Russias Military Offensive in Ukraine deals with a Bird Flu. Those who think China was behind COVID on its own might suggest reciprocation. Of course if either country suspected a Biological Attack we might see some Missiles Flying by instead of Balloons.
Ok, this part is hyperbolic, but it might make a good movie. Get on it Hollywood.
Of course, we could turn it around and release it in the West and then blame China or Russia and reverse this. Hollywood might like this version better